American Bio Medica Corp. (ABMC)

OTCMKTS: ABMC · Delayed Price · USD
0.0181
0.0000 (0.00%)
Jun 24, 2022 4:00 PM - Market closed
0.00%
Market Cap 870,581
Revenue (ttm) 2.00M
Net Income (ttm) -286,000
Shares Out 48.10M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10
Open 0.0230
Previous Close 0.0181
Day's Range 0.0181 - 0.0181
52-Week Range 0.0181 - 0.1000
Beta -1.38
Analysts n/a
Price Target n/a
Earnings Date n/a

About ABMC

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detec... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Dec 24, 1997
Employees 32
Stock Exchange OTCMKTS
Ticker Symbol ABMC
Full Company Profile

Financial Performance

In 2020, ABMC's revenue was $4.15 million, an increase of 13.46% compared to the previous year's $3.66 million. Losses were -$796,000, 16.9% more than in 2019.

Financial Statements

News

ABMC Reports Third Quarter 2021 Results

KINDERHOOK, NY / ACCESSWIRE / November 18, 2021 / American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three and nine months ended September 30, 2021. Chief Executive O...

ABMC Reports Second Quarter 2021 Results

KINDERHOOK, NY / ACCESSWIRE / August 18, 2021 / American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three and six months ended June 30, 2021. Chief Executive Officer M...

ABMC Reports First Quarter 2021 Results

KINDERHOOK, NY / ACCESSWIRE / May 20, 2021 / American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three months ended March 31, 2021. Chief Executive Officer Melissa A.